In summary, our current findings exhibited that Artemisinin commendably repressed FoxM1 at its transcriptional level and curbed its downstream trans-activation ability, thus delaying cancer cell proliferation, relegating tumor growth and increasing apoptosis (Figure 8). Here, FOXM1 is linked to neoplasm.